|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM376371110 |
| 003 |
DE-627 |
| 005 |
20240816233044.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240816s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202405318
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1503.xml
|
| 035 |
|
|
|a (DE-627)NLM376371110
|
| 035 |
|
|
|a (NLM)39149782
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Zhang, Wenting
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Smart Bioorthogonal Nanozymes
|b From Rational Design to Appropriate Bioapplications
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 16.08.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status Publisher
|
| 520 |
|
|
|a © 2024 Wiley‐VCH GmbH.
|
| 520 |
|
|
|a Bioorthogonal chemistry has provided an elaborate arsenal to manipulate native biological processes in living systems. As the great advancement of nanotechnology in recent years, bioorthogonal nanozymes are innovated to tackle the challenges that emerged in practical biomedical applications. Bioorthogonal nanozymes are uniquely positioned owing to their advantages of high customizability and tunability, as well as good adaptability to biological systems, which bring exciting opportunities for biomedical applications. More intriguingly, the great advancement in nanotechnology offers an exciting opportunity for innovating bioorthogonal catalytic materials. In this comprehensive review, the significant progresses of bioorthogonal nanozymes are discussed with both spatiotemporal controllability and high performance in living systems, and highlight their design principles and recent rapid applications. The remaining challenges and future perspectives are then outlined along this thriving field. It is expected that this review will inspire and promote the design of novel bioorthogonal nanozymes, and facilitate their clinical translation
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a bioapplications
|
| 650 |
|
4 |
|a bioorthogonal nanozymes
|
| 650 |
|
4 |
|a drug synthesis
|
| 650 |
|
4 |
|a nanocatalysis
|
| 650 |
|
4 |
|a nanozymes
|
| 700 |
1 |
|
|a Zhu, Jiawei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ren, Jinsong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Qu, Xiaogang
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g (2024) vom: 16. Aug., Seite e2405318
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g year:2024
|g day:16
|g month:08
|g pages:e2405318
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202405318
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2024
|b 16
|c 08
|h e2405318
|